Palmer Ashleigh 4
4 · Provention Bio, Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
Palmer Ashleigh
Director and CEO
Transactions
- Award
Stock Option (right to buy)
[F2][F1]2023-01-17+700,000→ 700,000 totalExercise: $10.46Exp: 2033-01-17→ Common Stock, par value $0.0001 (700,000 underlying)
Footnotes (2)
- [F1]The options will vest and become exercisable as to 25% on the one-year anniversary of the grant date (January 17, 2024) and the remaining 75% will vest and become exercisable monthly over 36 months such that the options are fully vested and exercisable on the four-year anniversary of the grant date (January 17, 2027).
- [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.
Signature
/s/ Thierry Chauche, as attorney-in-fact|2023-01-18